Understanding why bipolar disorder can emerge or worsen in adulthood — long after neural development is complete — has been one of psychiatry's most persistent puzzles. New findings from a PNAS study challenge the assumption that bipolar-relevant gene effects are purely developmental, showing instead that disrupting a single protein in mature neurons is sufficient to produce the disorder's hallmark features.
The research focused on Ank3, the gene encoding Ankyrin-G, a scaffolding protein previously flagged in genome-wide association studies as one of the strongest genetic risk factors for bipolar disorder. Using conditional deletion restricted to adult forebrain excitatory neurons, the investigators demonstrated that removing Ankyrin-G in already-mature tissue — bypassing developmental compensation — was sufficient to produce bipolar disorder-like behavioral phenotypes. The loss of Ankyrin-G reduced neuronal firing activity and produced measurable disruptions across three interconnected domains: the membrane proteome (the constellation of proteins anchored at neuronal surfaces), and, strikingly, myelination — the insulating sheath around axons critical for signal speed and fidelity.
This three-way convergence of electrophysiological, proteomic, and structural white-matter disruption in a single adult-onset model is analytically significant. Prior work on Ank3 largely examined developmental or constitutive knockouts, making it difficult to disentangle adult function from developmental roles. By isolating the adult context, this model clarifies that Ankyrin-G is not merely a developmental architect but an ongoing regulator of mature circuit integrity. The myelination finding is particularly noteworthy: white-matter abnormalities have been documented in neuroimaging studies of bipolar patients for years, but causal mechanistic links have remained elusive. That a single scaffolding protein's absence in excitatory neurons could perturb oligodendrocyte-mediated myelination suggests non-cell-autonomous signaling pathways worth investigating. Limitations include the mouse model's inherent translational ceiling and the excitatory-neuron specificity, which may not capture the full complexity of human Ank3 haploinsufficiency across cell types.